Open Access
Rashaa Hadi Saleh1 , Eman Fadhel Abd Al-Hussien2 and Zaytoon Abulrdia Ighawish3
1College of Pharmacy, University of Babylon, Iraq.
2College of Biotechnology, Al-Qasim Green University, Iraq.
3College of Medicine Babylon, University of Babylon, Iraq.
J Pure Appl Microbiol. 2018;12(3):1483-1487
https://doi.org/10.22207/JPAM.12.3.52 | © The Author(s). 2018
Received: 25/05/2018 | Accepted: 20/07/2018 | Published: 30/09/2018
Abstract

Cytomegalovirus1(CMV)i is one of the essential causes o of intrauterine contagions. The contagion is commonly asymptomatic in immunocompotent adults, but its import in various times elevated when it happens throughout pregnancy. Pregnant women with CMV i infection can be responsible for abortion  or congenital malformation.  This subject was aimed to estimate the prevalence of cytomegalovirus virus amid pregnant women in Babylon province and evaluation of some haematological and immunological parameters in women infected with CMV. The study was conducted on (145) pregnant women referred to the Babylon Teaching Hospital for Maternity and Children to investigate the prevalence of Cytomegalovirus in Babylon province. Overall of  (145) pregnant women was contained in this study, CMV specific IgM and IgG antibody were detected by minividas-test. Blood hemoglobin (Hb) concentration, neutrophil and lymphocyte accounts were determinate. Single radial immune diffusion plates were used for assessment of  C3 and C41 level in infected women. Among 145 pregnant women were evaluated for CMV, (95.1%) were positive toward I IgG and (4.1%) were positive toward I IgM. Most of CMV infections  among women with age ranging between 20-29 years. It was found that there was a increase in the lymphocyte count  and complement components C3 and decrease in the C4 level among CMV patients compared to control group, while haemoglobin and neutrophile level appeared normal. This study summarized that there are  increasing seropositivity rate for r human cytomegalovirus amid pregnant women The prevalence of CMV was relatively high in our locality.

Keywords

CMV, IgM, IgG. Pregnant women, Babylon

Introduction

Pregnancy leads to temporary immune inhibition, that may be causing increase exposure of pregnant women to infection1. Several viral infections are correlated with  essential maternal and fetal sequels if  get throughout pregnancy and causes abortion, the most commonly encountered infections is Cytomegalovirus (CMV) infections2. CMV is endemic all over the world. It’s part of Herpesviridae family that infects human. It is also  called as human herpesvirus 5 (HHV5). is can be transfer via saliva, , breast milk, placenta, breast feeding, sexual contact blood transfer and organ transplantation3,4,5.

HCMV infection may be a symptomatic, or may include mononucleosis like symptoms with prolonged fever and mild hepatitis1. CMV is t the most frequent causes o of congenital infection. A primitive infections happen in 0.15 to 2.0% of  whole pregnancies and causing many risk to the fetuses of f pregnant women1. The transferee of CMV 1 can happen throughout primary 1maternal infection 1or during non-primary infection (revive and reinfection)) of seropositive  mothers, but t the transfer rate to the fetus is a lot of higher for r  non-immune mothers (up to1 40%) than for immune mothers (0 to.1%)6. Monocyte/macrophages and endothelial cells are considered places of CMVsurvival, latency and reproduction and its important in maintaining life-long infection7. CMV (infection in non)-immunocompromised individuals can -shift of immune-response during)pregnancy from Th2 to-Th1 and apoptosis which can be seen clinically as an abortion developed9.

CMV /infection of immunocompetent persons induce a humoral0immune response and the consequent  production of stable-levels of anti-1CMV IgG antibodies10. A preceding researches have proved that1the cellular immune) response to1 CMV is of essential interest in eradicating the virus from the host1in a murine model. CD8_1T lymphocytes are considered to be an vital host)defense against-viruses11.

Materials and Methods

Samples collection
This study was done on  pregnant women  aged between (10-50) years who attending0to the Babylon Teaching Hospital for-Maternity and l Children in Babylon province during the period of one year (2017). Five ml of blood samples were collected from pregnant women and   immunocompetent  nonpregnant women as control and then divided into  two tubes, 3ml of blood put in plain tubes for separation of serum and the remain 2ml of blood put in EDTA tube for hematological test. Sera was used  for the detection of antibodies (IgG and IgM) specific to CMV using a minividas test (kits/ BioCheck-USA).

For hematological test,  anticoagulated blood samples in EDTA tube)were used to determine concentration of blood hemoglobin (Hb). and percentage of neutrophile and lymphocyte12,13.

Complement components C3 and C4 level  were determined in patients and control group by using single radial immune diffusion. Five µl of serum sample or control were applied. The lid was closed firmly, incubated at room temperature 25 ºC and the diameter was measured accurately14.

Statistical analysis
Data have been analyzed statistically using SPSS program version 11. Analysis of quantitative data was done using t-test

RESULTS AND DISCUSSION

Seroprevalence of CMV
This study was carried out on  pregnant women to examine the seropositivity rates of IgG-and IgM1 specific to CMV.  The results of this study showed that among 140 tested pregnant women, (4.1%%) were positive for IgM antibodies, (95.1%%) were positive for IgG and (2%) were positive for both IgM-and IgG (Table 1). The results of current study was close to other studies like9,3 who found that  IgG was detected  in (90.2%) and  (97.5%)  and  IgM in (9.18 %) and (6.0%) of pregnant women respectively.

Table (1):
The seroprevalence rate of anti-CMV IgM) and IgG antibodies among pregnant women.

No. of tested women CMV IgG CMV IgM CMV  IgM  and IgG
 No. of +ve % of  +ve No. of +ve % of +ve No. of +ve % of  +ve
145 6 4.1% 138 95.1%    3 2%

Variable IgM-positivity were recorded worldwide, only 1% in Turkey1, 2.5% in Iran, 2.5 in Western Sudan and 1.7% in Korea3. Positive IgM results to) Cytomegalovirus (CMV) are indicated of a primitive or repeated infection. IgM (antibodies to CMV can continue for (2 to 9 )months after the initial infection. Not all patients with reactivated CMV infection will) have noticeable levels of IgM antibodies15.

The seroprevalance of-CMV IgG detected in this7study was similar-to the findings-reported by16,17. The higher percentage of CMV-IgG seropositivity are indicative of past (CMV) infection, specifically  when they were IgM)-negative, these women1as mentioned can cassumed immune and their primary infection with CMV was) consider to have been happen before the present pregnancy and they were mostly asymptomatic1personnel15,18.

In this study CMV is endemic in our population. The high prevalence proved that CMV is simply transmitted than a some other i infections like as measles.  Specific)care and appropriate vaccination program are needed to prevent the transmission of CMV19.

The results of the present study showed that highest seropositivity rate of CMV 5(55.5%%) was seen among age group 20-30 years, while others age groups showed percentage of 3(33.3%) for age group 10-20 and (11.1%) for age group 30-40 years (Table 2). These results  were confirmed by (20, 21,19) who stated  that most CMV infections seen among age group 20-30- years.  Age group 20-30  was determined as the major age group for the occurrence of CMV primary infections  and this may be due to that  most marriages in our population occurred among the this age group.

Table (2):
Distribution of infected women with CMV according to age.

Age group/ Year
No. of +ve patients with CMV
% of +ve patients with CMV
10-20
1
11.1%
20-30
5
55.5%
30-40
3
33.3%
40-50
0
0

In Iraq, Our study has shown that the common of women of gestation age are seropositive for CMV and that they deal with  the infection either through prenatal or postnatal transmission or during early childhood.                                                                                                          

Estimation of Immunological and hematological parameters
Concerning the serum complement components level in CMV patients . It was found that there are increase in the levels of C3 (204.40 ±20.33) in patient group compared to control group (105.03 ±10.84  ) and decrease in the level of C4 (10.52±  3.47) among patients group compared to control group (35.92 ±6.77) as shown in (Table 3,4).

Table (3):
Mean concentration of C3 in patients and control sera (mg/dl).

Group No. CMV + C3
Means std Std. error
Patients 30 204.4000 20.33000 3.71173
Control 15 105.0333 10.84341 2.79976

Table (4):
Mean concentration of C4 in patients and control sera (mg/dl).

Group No. CMV+ C4
Means std Std. error
Patients 30 10.5200 3.47150 .63381
Control 15 35.9267 6.77184 1.74848

The complement0system is increasingly observed as a mediator-of defense or i pathology in a numerous of viral) infections. The antiviral  mechanism for complement is frequently illustrated by that the antibodies detecting viral antigens) on the infected cell surface or virion -envelope, and this would in return promote complement activation in cascades which accumulate the complement complex) leading to membrane distraction, known as (CDC) or virolysis. In addition, complement-improve neutralization without virolysis has been designated, and one suggested mechanism for this is that the gathering of complement on viral envelop would prevent viral interplay with its cellular receptor needed for viral passage22.

The hematological parameters showed that hemoglobin(Hb) concentration and  neutrophil   count in CMV patients were (13.0233)  and (75.2300) in comparison  with control group (12.8733) and (74.2800) respectively with no differences between them (Table 5). Similar findings recorded by  (9) who found that CMV s seropositivity have no1significant 1effect on some blood parameters included Hb concentration, While23 reported significant decrease for hemoglobin Hb  and neutrophil count among CMV patients. CMV is intracellular virus could be localized in leukocytes and is concentrated in neutrophil fraction of the buffy coat24.

Table (5):
Haematological parameters in CMV patients.

Groups Hematological parameters
No. Hemoglobin(g/dl) neutrophil (%) lymphocyte (%)
Meann Std. Std.error Mean Std Std. error Mean Std Std. error
Patients 30 13.0233 1.20650 .22028 75.2300 3.08032 .56239 41.9967 6.65290 1.21465
Control 15 12.8733 1.23315 .31840 74.2800 2.88499 .74490 22.6867 1.49564 .38617

The results of present study revealed increase in the levels of lymphocyte  in CMV patients (41.9967)  in comparison to control  group (22.6867). Our results were in-parallel with others observations recorded by others researchers, who noticed elevated level of lymphocyte in CMV patients23,25. In Contrast, The authors9 stated that patients with CMV has normal level of lymphocyte.

Primary HCMV infection is characterized by an intense viral replication and a profound T-cell response that may last for several months, with both CD8+ cytotoxic and CD4+ helper T-cells playing central roles in the resolution of acute primary infection and the maintenance of long-term memory during viral persistence. HCMV-specific cytotoxicity is predominantly performed by (CDi8+ T-)cells, although HCMV-specific

CD4+  (Ti-cells)  also have the ability to lyse infected target cell26, as well as maintain the upkeep of the CD8+ T-cell population.  The virus is also capable of periodic reactivation causing large-scale expansions of cytotoxic T-cells that seem to linger long after the infection has been curtailed. Consequently,  people with a latent HCMV infection have substantially increased numbers and proportions of CD8+ (and to some extent CD4+) T-cells27.

CONCLUSION

This study concluded that CMV infection is common among  pregnant women in our local population and this high seroprevalence reflect the low hygienic standards and low community education . Also the many ways of viral transmission have the role in spreading the viral infection, Missing of effective viral treatment play an major role in the transference of the virus from mother t to fetus and cause either abortion or congenital malformations. Hence periodically screening of women of child bearing i age for CMV -infection is wanted  in order to decrease the fatal consequence of the pregnancy appearing due to the CMVi infection.

Declarations

ACKNOWLEDGMENTS
The authors acknowledge the members and staff of Babylon Teaching Hospital for Maternity and Children in In Babylon province for helping in collecting the samples, data and their excellent technical assistance. Authors also thank all patients who participated in this study

CONFLICT OF INTEREST
The authors declare that there is no conflict of interest.

References
  1. Salman. Y.G. Serological Cross Reaction among Songle Causative Agents Of Women Abortions(Toxoplasma gondii and Cytmegalo Virus AND Rubella Virus) with the Incidence of Hepatitis Virus(B and C). Tikrit Journal of Pharnnceutical  Sciences. 2007; 3 (2):102 – 111.
  2. Janna, M.A.;Al-shanawee, F.A.; Waheeda,N.E. and Al-Anny, N.G. Evaluation the immunological state of women´s sera infected with Toxoplamosis. QMJ. 5(.8):80-98.
  3. Khairi, S.I.; Intisar, K.H.;Enan; K.H.; Ishag, M.Y. Baraa, A.M. and Ali, Y.H. Seroprevalence of cytomegalovirus infection among pregnant women at Omdurman Maternity Hospital, Sudan Journal of Medical Laboratory and Diagnosis. 2013; 4(4):45-49.
  4. Al-Hindawi, N.Gh,  and Al-Shanawi, F.A. Seroprevalence of Toxoplasma gondii and Cytomegalovirus in Aborte Women in Baghdad-Iraq. Iraqi Journal of Science, 2015; 56(C)649-655.
  5. Hussan, B.M. Study the Prevalence of ACL,APL,CMV,HSV, Rubella and Toxoplasma Gondii in Aborted Women in Baghdad Medical Journal of Babylon. 2013; 10(2):455-464.
  6. Lagrou, K.; Bodeus, M.; Van Ranst, M. and Goubau, P. Evaluation of the New Architect Cytomegalovirus Immunoglobulin M (IgM), IgG, and IgG Avidity Assays. Journal of Clinical Microbiology. 2009; 47(6):1695–1699.
  7. Jianhui, Z.; Shearer, G.M.;Marincola, F.M.; Norman, J.E.; Rott, D.;Zou, J; Epstein, S.E. Discordant cellular and humoral immune responses to cytomegalovirus infection in healthy blood donors: existence of a Th1-type dominant response  International Immunology 2001; 13(6):785–790.
  8. Kadum, S.A. and Abbas, A.F. A study of some immunological features in aborted women infected with Toxoplasma gondii and Cytomegalovirus in Hilla city. AL-Qadisiy a J. Sci., 2013; 18(4): 62-70.
  9. Hama, S.A. and Abdurahman, K.J. Human Cytomegalovirus IgG and IgM Seropositivity among Pregnant Women in Sulaimani City and Their Relations to the Abortion Rates. Current Research Journal of Biological Sciences, 2013; 5(4): 161-167.
  10. Spiller, O.B.; Hanna, M.; Devine,  D.V. and Tufaro, F. Neutralization of Cytomegalovirus Virions: The Role of Complement. The Journal of Infectious Diseases; 1997; 176: 339–347.
  11. Simpson, R.J.; Biqley, A.B.; Spielmann, G; LaVoy, E.C.; Kunz, H, and Bollard, C.M. Human cytomegalovirus infection and the immune response to exercise. Exerc Immunol Rev.; 2016; 22:8-27.
  12. Voigt, G. L. Hematology Techniques Cconcepts for Veterinary Technician, 1st ed., lowa state university press 2000; pp28-52.
  13. Pilaski, J. (1972). Cited by Sturkie, P. D. & Griminger, P. Blood fluid: In Sturkie, P. D. (ed). Avian physiology .4th ed. Springer- verlog. New york Berlin, Heidelberg.Tokyo, 1982; pp.113-114.
  14. Lewis, S.M.;Bain, B.J. and Bates, I. Dacie and Lewis.Practical Hematology.9thed. Churchils livingstone,London 2001.
  15. Ahmed, Z.K.; Ahmed,  Z.K.  and Salman, Z.Q. Quantitative Detection of Human Cytomegalovirus (HCMV) Gene in Iraqi Women with Pregnancy Associated Problems. Iraqi Journal of Biotechnology, 2014; 13(1):30-38.
  16. Nahla, K.H.; Ali, Y.H. and Enan, K.H. Studies on congenital infections in  Sudan: Seroprevalence of cytomegalovirus. J. Sci. Tech. 2011; 12(4):82-90.
  17. Kafi, S.K.; Eldouma; E.Y.; Saeed, S.B.M. and Musa, H.A. Seroprevalence of Cytomegalovirus among blood donors and antenatal women attending two hospitals in Khartoum State. Sudan J.  Med.  Sci.; 2009; 4(4):399-401.
  18. Nader, S. and Ayad, M. “Cytomegalovirus Seroprevelance in Iraqi Pregnant Women”. The Iraqi Postgraduate Medical Journal. 2012; 11(3): 304-307.
  19. Shams, S.; Ayaz, S.; SKhan, s.; Khan, S.N.; Gul, I.; Attaullah, S.; Parveez, R.; Farzand, R. and Hussain,M. Prevalence and detection of cytomegalovirus by polymerase chain reaction (PCR) and simple ELISA in pregnant women. African Journal of Biotechnology .; 2011; 10(34); 6616-6619.
  20. Abd-ul-Aziz, S. Sero-prevalence of anti- CMV- IgM and anti -CMV- IgG in Iraqi Aborted Women Infected with Human Cytomegalovirus in Nasiriyah city. J.Thi- Qar.; 2015; 10(4):55-60.
  21. Al-shammary, R.N. Prevalence of Cytomegalovirus among pregnant women relation to congenital abnormalities in embryos and children in Wasit province. J. Kerb Univ.; 2014; 12(1):86-91.
  22. Li, F.; Freed, D.C.; Tang, A.; Rustandi, R.R.; Troutman, M.C; Espeseth, A.S.; Zhang, N.; An, Z.; McVoy, M.; Zhu, H.; Ha, S.; Wang, D.; Adler, S.P. and Fu, T. Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination. npj Vaccines, 2017; 2:36:1-8.
  23. Alebady, F.A.M.; Salman, A.N. and Hadi, N.A. Detection of some Immunological parameters Related with Cytomegalovirus (CMV) Infections in aborted women at THI-QAR province in south of IRAQ. Al-Qadisiyah J. Pure Scie., 2016; 21(3):69-77.
  24. Bonnet, F,.; Morlat, P.; Neau, D.; Viallard, J.F.; Ragnaud, J.M.; Dupon, M.; Legendre, P.;  Imbert, Y.; Lifermann, F.; Le Bras, M.;  Beylot,J. and Longy-Boursier, M. Hematologic and immunologic manifestations of primary cytomegalovirus infections in non-immunocompromised hospitalized adults. Rev Med Interne.; 2000; 21(7):586-94.
  25. Michael; O,A,; Theresa, O.A.; Olusayo, A.O. and Nwadioha, S.I. Assessment of Some Key Haematological Parameters on Cytomegalovirus Antibody Positive Pregnant Women in Makurdi Nigeria. International Blood Research & Reviews 2017; 7(3): 1-8.
  26. Simpson, R.J.; Bigley, A.B.; Spielmann, G.; LaVoy, E.C.P.; Kunz, H.; and Bollard, C.M. Human cytomegalovirus infection and the immune response to exercise Exerc Immunol Rev.; 2016; 22:8-27.
  27. Cicin-Sain, L.; Brien, J.D.; Uhrlaub, J.L.; Drabig, A.; Marandu, T.F.; and Nikolich-Zugich, J. Cytomegalovirus Infection Impairs Immune Responses and Accentuates T-cell Pool Changes Observed in Mice with Aging. PLoS Pathog. 2012; 8(8):

Article Metrics

Article View: 2191

Share This Article

© The Author(s) 2018. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.